Arbuckle Stuart A bought ALNY
January 5, 2026 · Form 4 insider transaction
Arbuckle Stuart A bought 3,279 shares of Alnylam Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,279
Price
$0.00
Total value
N/A
InsiderArbuckle Stuart A
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after3,279
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.